| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.00e-05 | 44 | 73 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TAOK2 RALGDS RIN2 IQSEC2 PHACTR4 ARHGAP17 SMO GMIP SKI ARHGAP8 MMP16 CCNK SYDE1 SOCS7 TNS3 SOS2 | 4.24e-05 | 1418 | 73 | 16 | GO:0030234 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 9.37e-05 | 507 | 73 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 9.37e-05 | 507 | 73 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.12e-04 | 68 | 73 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.19e-04 | 69 | 73 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.33e-04 | 71 | 73 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.91e-04 | 229 | 73 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | actin binding | SPATA31A1 SPATA31A3 MICALL2 SPATA31A7 PHACTR4 SPATA31A6 SPATA31C1 SPATA31A5 | 3.55e-04 | 479 | 73 | 8 | GO:0003779 |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 5.53e-04 | 103 | 73 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 5.82e-04 | 10 | 73 | 2 | GO:0140537 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 5.82e-04 | 10 | 73 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 5.95e-04 | 105 | 73 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 6.28e-04 | 656 | 73 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 7.10e-04 | 11 | 73 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.00e-03 | 13 | 73 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TAOK2 VGF BICRA RIN2 PHACTR4 ARHGAP17 GMIP ARHGAP8 MMP16 CCNK SYDE1 NSD3 | 1.61e-03 | 1233 | 73 | 12 | GO:0140677 |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.82e-03 | 66 | 73 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.82e-03 | 66 | 73 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.40e-03 | 20 | 73 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.56e-03 | 279 | 73 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.65e-03 | 172 | 73 | 4 | GO:0008757 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.42e-03 | 562 | 73 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.06e-03 | 891 | 73 | 9 | GO:0008270 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SETDB1 SETD2 KMT2D TCF7L2 IRX5 ZPR1 KIAA1217 PHACTR4 DVL2 KDM2B SMO SKI MMP16 CCNK SYDE1 | 7.53e-07 | 906 | 75 | 15 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SETDB1 SETD2 KMT2D TCF7L2 IRX5 ZPR1 KIAA1217 PHACTR4 DVL2 KDM2B SMO SKI MMP16 CCNK SYDE1 | 1.03e-06 | 929 | 75 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RALGDS RIN2 IQSEC2 PHACTR4 ARHGAP17 ROBO1 GMIP ARHGAP8 SYDE1 TNS3 SOS2 | 3.72e-06 | 538 | 75 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | neural tube development | 8.80e-06 | 202 | 75 | 7 | GO:0021915 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 2.80e-05 | 333 | 75 | 8 | GO:0051056 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | VGF KMT2D TCF7L2 IRX5 SPATA31A1 SPATA31A3 SPATA31A7 SPATA31C2 KDM2B EIF4G3 DEDD SPATA31A6 SPATA31C1 SPATA31A5 SPEM1 | 3.19e-05 | 1235 | 75 | 15 | GO:0003006 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 4.06e-05 | 351 | 75 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryo development | SETDB1 SETD2 KMT2D TCF7L2 IRX5 ZPR1 KIAA1217 PHACTR4 DVL2 KDM2B SMO SKI MMP16 CREBBP CCNK SYDE1 | 4.78e-05 | 1437 | 75 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | neural tube closure | 5.74e-05 | 113 | 75 | 5 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 5.99e-05 | 114 | 75 | 5 | GO:0060606 | |
| GeneOntologyBiologicalProcess | spermatogenesis | SPATA31A1 SPATA31A3 SPATA31A7 SPATA31C2 KDM2B EIF4G3 DEDD SPATA31A6 SPATA31C1 SPATA31A5 SPEM1 | 7.46e-05 | 744 | 75 | 11 | GO:0007283 |
| GeneOntologyBiologicalProcess | primary neural tube formation | 7.64e-05 | 120 | 75 | 5 | GO:0014020 | |
| GeneOntologyBiologicalProcess | male gamete generation | SPATA31A1 SPATA31A3 SPATA31A7 SPATA31C2 KDM2B EIF4G3 DEDD SPATA31A6 SPATA31C1 SPATA31A5 SPEM1 | 9.23e-05 | 762 | 75 | 11 | GO:0048232 |
| GeneOntologyBiologicalProcess | neural tube formation | 1.29e-04 | 134 | 75 | 5 | GO:0001841 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SETDB1 SIN3B TCF7L2 ZBTB39 ATF7IP MBD1 YLPM1 KDM2B SMO SKI DEDD CREBBP TFAP4 NSD3 SCAF4 | 1.31e-04 | 1399 | 75 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SETDB1 SIN3B TCF7L2 ZBTB39 ATF7IP MBD1 YLPM1 KDM2B SMO SKI DEDD CREBBP TFAP4 NSD3 SCAF4 | 1.46e-04 | 1413 | 75 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.94e-04 | 561 | 75 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | gamete generation | KMT2D SPATA31A1 SPATA31A3 SPATA31A7 SPATA31C2 KDM2B EIF4G3 DEDD SPATA31A6 SPATA31C1 SPATA31A5 SPEM1 | 2.07e-04 | 982 | 75 | 12 | GO:0007276 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 2.24e-04 | 237 | 75 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | sexual reproduction | VGF KMT2D SPATA31A1 SPATA31A3 SPATA31A7 SPATA31C2 KDM2B EIF4G3 DEDD SPATA31A6 SPATA31C1 SPATA31A5 SYDE1 SPEM1 | 2.39e-04 | 1312 | 75 | 14 | GO:0019953 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.49e-04 | 713 | 75 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 2.51e-04 | 242 | 75 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 2.86e-04 | 159 | 75 | 5 | GO:0001838 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TAOK2 SETDB1 PHF23 TRAPPC12 ATXN7 ATF7IP YLPM1 DVL2 CUL9 ARHGAP17 RIMBP2 ATG2A EIF4G3 SYDE1 | 3.02e-04 | 1342 | 75 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | epithelial tube formation | 4.21e-04 | 173 | 75 | 5 | GO:0072175 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 4.46e-04 | 41 | 75 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | regulation of heart morphogenesis | 4.62e-04 | 9 | 75 | 2 | GO:2000826 | |
| GeneOntologyBiologicalProcess | glycogen metabolic process | 4.67e-04 | 99 | 75 | 4 | GO:0005977 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 5.04e-04 | 101 | 75 | 4 | GO:0044042 | |
| GeneOntologyBiologicalProcess | tube formation | 6.00e-04 | 187 | 75 | 5 | GO:0035148 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 6.44e-04 | 190 | 75 | 5 | GO:0016331 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase I | 7.02e-04 | 11 | 75 | 2 | GO:0016479 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 7.10e-04 | 48 | 75 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 7.95e-04 | 114 | 75 | 4 | GO:1900182 | |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 7.95e-04 | 114 | 75 | 4 | GO:0006112 | |
| GeneOntologyBiologicalProcess | glycophagy | 8.41e-04 | 12 | 75 | 2 | GO:0061723 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 8.45e-04 | 421 | 75 | 7 | GO:0060562 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 8.98e-04 | 52 | 75 | 3 | GO:0048701 | |
| GeneOntologyBiologicalProcess | positive regulation of heterochromatin formation | 9.92e-04 | 13 | 75 | 2 | GO:0031453 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 9.03e-05 | 206 | 74 | 6 | GO:0001669 | |
| GeneOntologyCellularComponent | nuclear body | CBLL1 SRRM1 TCF7L2 ATF7IP ZPR1 MBD1 YLPM1 DVL2 SKI VIRMA CREBBP | 3.18e-04 | 903 | 74 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 4.38e-04 | 9 | 74 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | dendritic growth cone | 7.97e-04 | 12 | 74 | 2 | GO:0044294 | |
| HumanPheno | Chiari type I malformation | 1.78e-06 | 48 | 23 | 5 | HP:0007099 | |
| HumanPheno | Chiari malformation | 5.63e-06 | 107 | 23 | 6 | HP:0002308 | |
| HumanPheno | Abnormality of the hairline | 2.56e-05 | 294 | 23 | 8 | HP:0009553 | |
| HumanPheno | Reduced circulating growth hormone concentration | 3.53e-05 | 15 | 23 | 3 | HP:0034323 | |
| HumanPheno | Obesity | 5.10e-05 | 425 | 23 | 9 | HP:0001513 | |
| HumanPheno | Congenital abnormal hair pattern | 5.54e-05 | 327 | 23 | 8 | HP:0011361 | |
| HumanPheno | Abnormality of the scalp hair | 5.91e-05 | 433 | 23 | 9 | HP:0100037 | |
| HumanPheno | Abnormal eyebrow morphology | SETD2 KMT2D IRX5 BICRA RIN2 IQSEC2 ROBO1 SKI CREBBP CCNK SOS2 | 5.99e-05 | 674 | 23 | 11 | HP:0000534 |
| HumanPheno | Abnormal hair pattern | 6.16e-05 | 676 | 23 | 11 | HP:0010720 | |
| HumanPheno | Abnormal scalp morphology | 8.02e-05 | 450 | 23 | 9 | HP:0001965 | |
| HumanPheno | Low hanging columella | 9.93e-05 | 56 | 23 | 4 | HP:0009765 | |
| HumanPheno | Abnormality of the forehead | SETD2 KMT2D IRX5 BICRA RNPC3 ZPR1 RIN2 IQSEC2 ROBO1 SMO SKI CREBBP CCNK SOS2 | 1.49e-04 | 1208 | 23 | 14 | HP:0000290 |
| HumanPheno | Increased body weight | 1.59e-04 | 491 | 23 | 9 | HP:0004324 | |
| HumanPheno | Abnormal size of the palpebral fissures | 2.37e-04 | 298 | 23 | 7 | HP:0200007 | |
| HumanPheno | Hirsutism | 2.98e-04 | 216 | 23 | 6 | HP:0001007 | |
| HumanPheno | Abnormal cerebral white matter morphology | SIN3B SETD2 KMT2D REPS1 TRAPPC12 RIN2 IQSEC2 ROBO1 SMO SKI CREBBP GAA SCAF4 | 3.04e-04 | 1114 | 23 | 13 | HP:0002500 |
| HumanPheno | High anterior hairline | 3.27e-04 | 76 | 23 | 4 | HP:0009890 | |
| HumanPheno | Brachydactyly | 3.30e-04 | 670 | 23 | 10 | HP:0001156 | |
| HumanPheno | Short digit | 3.38e-04 | 672 | 23 | 10 | HP:0011927 | |
| HumanPheno | Hypertrichosis | 3.51e-04 | 425 | 23 | 8 | HP:0000998 | |
| HumanPheno | Pectus excavatum | 3.91e-04 | 323 | 23 | 7 | HP:0000767 | |
| HumanPheno | Micrognathia | SETD2 KMT2D IRX5 BICRA RIN2 IQSEC2 ROBO1 SMO SKI CREBBP SOS2 | 4.70e-04 | 843 | 23 | 11 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | SETD2 KMT2D IRX5 BICRA RIN2 IQSEC2 ROBO1 SMO SKI CREBBP SOS2 | 4.80e-04 | 845 | 23 | 11 | HP:0009118 |
| HumanPheno | Abnormal growth hormone level | 5.12e-04 | 154 | 23 | 5 | HP:0032367 | |
| HumanPheno | Intestinal malrotation | 5.60e-04 | 157 | 23 | 5 | HP:0002566 | |
| HumanPheno | Abnormality of the philtrum | 6.40e-04 | 726 | 23 | 10 | HP:0000288 | |
| HumanPheno | Pilomatrixoma | 6.89e-04 | 9 | 23 | 2 | HP:0030434 | |
| HumanPheno | Abnormality of the palpebral fissures | 6.89e-04 | 880 | 23 | 11 | HP:0008050 | |
| HumanPheno | Abnormal cerebral subcortex morphology | SIN3B SETD2 KMT2D REPS1 TRAPPC12 RIN2 IQSEC2 ROBO1 SMO SKI CREBBP GAA SCAF4 | 7.01e-04 | 1207 | 23 | 13 | HP:0010993 |
| HumanPheno | Frontal bossing | 7.32e-04 | 738 | 23 | 10 | HP:0002007 | |
| HumanPheno | Abnormal hair quantity | 7.47e-04 | 888 | 23 | 11 | HP:0011362 | |
| HumanPheno | Abnormal shape of the frontal region | 7.56e-04 | 741 | 23 | 10 | HP:0011218 | |
| HumanPheno | Abnormal frontal bone morphology | 7.64e-04 | 742 | 23 | 10 | HP:0430000 | |
| HumanPheno | Prominent forehead | 8.24e-04 | 261 | 23 | 6 | HP:0011220 | |
| HumanPheno | Abnormal columella morphology | 8.29e-04 | 97 | 23 | 4 | HP:0009929 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 8.62e-04 | 368 | 23 | 7 | HP:0031432 | |
| Domain | DUF4599 | 2.62e-12 | 12 | 73 | 6 | PF15371 | |
| Domain | DUF4599 | 2.62e-12 | 12 | 73 | 6 | IPR027970 | |
| Domain | Post-SET_dom | 3.77e-07 | 16 | 73 | 4 | IPR003616 | |
| Domain | PostSET | 3.77e-07 | 16 | 73 | 4 | SM00508 | |
| Domain | POST_SET | 3.77e-07 | 16 | 73 | 4 | PS50868 | |
| Domain | SET | 1.95e-05 | 41 | 73 | 4 | PF00856 | |
| Domain | SET | 3.10e-05 | 46 | 73 | 4 | SM00317 | |
| Domain | SET_dom | 4.32e-05 | 50 | 73 | 4 | IPR001214 | |
| Domain | SET | 4.32e-05 | 50 | 73 | 4 | PS50280 | |
| Domain | RhoGAP | 1.01e-04 | 62 | 73 | 4 | SM00324 | |
| Domain | RhoGAP | 1.07e-04 | 63 | 73 | 4 | PF00620 | |
| Domain | RHOGAP | 1.14e-04 | 64 | 73 | 4 | PS50238 | |
| Domain | RhoGAP_dom | 1.14e-04 | 64 | 73 | 4 | IPR000198 | |
| Domain | - | 1.14e-04 | 64 | 73 | 4 | 1.10.555.10 | |
| Domain | AWS | 1.50e-04 | 5 | 73 | 2 | SM00570 | |
| Domain | AWS | 1.50e-04 | 5 | 73 | 2 | PS51215 | |
| Domain | AWS_dom | 1.50e-04 | 5 | 73 | 2 | IPR006560 | |
| Domain | Znf_PHD-finger | 2.59e-04 | 79 | 73 | 4 | IPR019787 | |
| Domain | RNA_pol_II-bd | 3.12e-04 | 7 | 73 | 2 | IPR006903 | |
| Domain | CTD_bind | 3.12e-04 | 7 | 73 | 2 | PF04818 | |
| Domain | Rho_GTPase_activation_prot | 3.91e-04 | 88 | 73 | 4 | IPR008936 | |
| Domain | PHD | 4.08e-04 | 89 | 73 | 4 | SM00249 | |
| Domain | RPR | 4.16e-04 | 8 | 73 | 2 | SM00582 | |
| Domain | CID | 4.16e-04 | 8 | 73 | 2 | PS51391 | |
| Domain | CID_dom | 4.16e-04 | 8 | 73 | 2 | IPR006569 | |
| Domain | Znf_PHD | 4.44e-04 | 91 | 73 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.23e-04 | 95 | 73 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.44e-04 | 96 | 73 | 4 | PS01359 | |
| Domain | Znf_CXXC | 8.10e-04 | 11 | 73 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 8.10e-04 | 11 | 73 | 2 | PS51058 | |
| Domain | Methyl_CpG_DNA-bd | 8.10e-04 | 11 | 73 | 2 | IPR001739 | |
| Domain | MBD | 8.10e-04 | 11 | 73 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 8.10e-04 | 11 | 73 | 2 | IPR016177 | |
| Domain | zf-CXXC | 8.10e-04 | 11 | 73 | 2 | PF02008 | |
| Domain | MBD | 8.10e-04 | 11 | 73 | 2 | SM00391 | |
| Domain | MBD | 8.10e-04 | 11 | 73 | 2 | PS50982 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.33e-03 | 14 | 73 | 2 | IPR019804 | |
| Domain | Znf_FYVE_PHD | 2.63e-03 | 147 | 73 | 4 | IPR011011 | |
| Domain | RasGEFN | 2.74e-03 | 20 | 73 | 2 | SM00229 | |
| Domain | RasGEF_N | 3.02e-03 | 21 | 73 | 2 | PF00618 | |
| Domain | PHD | 3.16e-03 | 75 | 73 | 3 | PF00628 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.31e-03 | 22 | 73 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 3.31e-03 | 22 | 73 | 2 | PS50212 | |
| Domain | RASGEF | 4.61e-03 | 26 | 73 | 2 | PS00720 | |
| Domain | - | 4.61e-03 | 26 | 73 | 2 | 1.25.40.90 | |
| Domain | RASGEF_CAT | 5.71e-03 | 29 | 73 | 2 | PS50009 | |
| Domain | ENTH_VHS | 5.71e-03 | 29 | 73 | 2 | IPR008942 | |
| Domain | Ubiquitin-rel_dom | 5.85e-03 | 184 | 73 | 4 | IPR029071 | |
| Domain | RasGEF | 6.11e-03 | 30 | 73 | 2 | PF00617 | |
| Domain | - | 6.11e-03 | 30 | 73 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 6.11e-03 | 30 | 73 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 6.11e-03 | 30 | 73 | 2 | IPR001895 | |
| Domain | RasGEF | 6.11e-03 | 30 | 73 | 2 | SM00147 | |
| Domain | RA | 6.51e-03 | 31 | 73 | 2 | SM00314 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 7.55e-07 | 46 | 53 | 5 | MM14933 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 6.23e-06 | 70 | 53 | 5 | M27231 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.24e-06 | 272 | 53 | 8 | M29619 | |
| Pathway | PID_AJDISS_2PATHWAY | 3.07e-05 | 48 | 53 | 4 | M142 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.75e-05 | 175 | 53 | 6 | MM14941 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 7.35e-05 | 22 | 53 | 3 | MM15924 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.77e-04 | 34 | 53 | 3 | M39771 | |
| Pubmed | 8.90e-17 | 6 | 76 | 6 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 8.90e-17 | 6 | 76 | 6 | 25930072 | |
| Pubmed | 1.16e-11 | 24 | 76 | 6 | 32212159 | ||
| Pubmed | SIN3B SETD2 KMT2D REPS1 PHACTR4 YLPM1 KDM2B PPP1R13B RPRD2 CREBBP CCNK NSD3 SCAF4 | 2.02e-10 | 549 | 76 | 13 | 38280479 | |
| Pubmed | SETDB1 SIN3B KMT2D TCF7L2 MRPL22 PHF23 ATXN7 BICRA ATF7IP YLPM1 KDM2B PPP1R13B CUL9 RPRD2 SKI CREBBP TFAP4 SCAF4 | 1.30e-09 | 1429 | 76 | 18 | 35140242 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 4.92e-08 | 154 | 76 | 7 | 16055720 | |
| Pubmed | Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. | 1.00e-07 | 5 | 76 | 3 | 15691849 | |
| Pubmed | RALGDS SETDB1 BICRA ATF7IP PPP1R13B ARHGAP17 ROBO1 CREBBP NSD3 SOS2 | 1.08e-07 | 486 | 76 | 10 | 20936779 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 SRRM1 SIN3B SETD2 KMT2D TCF7L2 ZBTB39 MBD1 YLPM1 KDM2B RPRD2 SKI TFAP4 NSD3 SCAF4 | 1.13e-07 | 1294 | 76 | 15 | 30804502 |
| Pubmed | 1.34e-07 | 268 | 76 | 8 | 33640491 | ||
| Pubmed | 1.67e-07 | 57 | 76 | 5 | 18022353 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NHSL1 SRRM1 KIAA1217 IQSEC2 MBD1 PHACTR4 ARHGAP17 EIF4G3 VIRMA SYDE1 TNS3 NSD3 | 3.56e-07 | 861 | 76 | 12 | 36931259 |
| Pubmed | Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response. | 8.34e-07 | 9 | 76 | 3 | 23395904 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 SETD2 KMT2D ATXN7 PHACTR4 YLPM1 KDM2B VIRMA CCNK TFAP4 SCAF4 | 9.51e-07 | 774 | 76 | 11 | 15302935 |
| Pubmed | TAOK2 CBLL1 VGF SIN3B ATF7IP KIAA1217 IQSEC2 YLPM1 DVL2 PPP1R3F RIMBP2 VIRMA | 1.16e-06 | 963 | 76 | 12 | 28671696 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.54e-06 | 857 | 76 | 11 | 25609649 | |
| Pubmed | TAOK2 CBLL1 SIN3B SETD2 REPS1 MICALL2 ATXN7 MBD1 KDM2B EIF4G3 VIRMA CCNK NSD3 SCAF4 | 3.97e-06 | 1497 | 76 | 14 | 31527615 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18319327 | ||
| Pubmed | Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. | 4.71e-06 | 2 | 76 | 2 | 16757475 | |
| Pubmed | Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IP. | 4.71e-06 | 2 | 76 | 2 | 26813693 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 4.71e-06 | 2 | 76 | 2 | 27999180 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETDB1 SETD2 ATF7IP KIAA1217 KDM2B PPP1R13B CUL9 ARHGAP17 CREBBP | 5.53e-06 | 588 | 76 | 9 | 38580884 |
| Pubmed | 5.76e-06 | 591 | 76 | 9 | 15231748 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SIN3B SETD2 REPS1 ATF7IP KIAA1217 YLPM1 DVL2 RPRD2 EIF4G3 CCNK SCAF4 | 5.76e-06 | 934 | 76 | 11 | 33916271 |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 7.62e-06 | 57 | 76 | 4 | 23080069 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.21e-05 | 351 | 76 | 7 | 38297188 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34463256 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12665513 | ||
| Pubmed | MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. | 1.41e-05 | 3 | 76 | 2 | 8941362 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30452683 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24464130 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 36893259 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 32103169 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 14536086 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.45e-05 | 361 | 76 | 7 | 30344098 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF7L2 ATXN7 BICRA KIAA1217 RIN2 RPRD2 EIF4G3 SKI ARHGAP8 MMP16 CREBBP TFAP4 SOS2 | 1.90e-05 | 1489 | 76 | 13 | 28611215 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.70e-05 | 398 | 76 | 7 | 35016035 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TAOK2 NHSL1 KMT2D REPS1 TRAPPC12 BICRA ANKRD34A CUL9 ARHGAP17 ATG2A NSD3 | 2.75e-05 | 1105 | 76 | 11 | 35748872 |
| Pubmed | 2.75e-05 | 399 | 76 | 7 | 35987950 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 28398509 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 12665582 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21283129 | ||
| Pubmed | NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. | 2.82e-05 | 4 | 76 | 2 | 24875858 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 35445296 | ||
| Pubmed | SRRM1 SETDB1 SETD2 ATXN7 BICRA MBD1 DVL2 CUL9 SKI CREBBP NSD3 | 3.00e-05 | 1116 | 76 | 11 | 31753913 | |
| Pubmed | 3.39e-05 | 83 | 76 | 4 | 28794006 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.27e-05 | 954 | 76 | 10 | 36373674 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.41e-05 | 430 | 76 | 7 | 35044719 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 29259132 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 17283070 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 39390582 | ||
| Pubmed | Physical association between the histone acetyl transferase CBP and a histone methyl transferase. | 4.69e-05 | 5 | 76 | 2 | 11252719 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 10823891 | ||
| Pubmed | 5.71e-05 | 34 | 76 | 3 | 30894540 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 12408825 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 38570506 | ||
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 7.03e-05 | 6 | 76 | 2 | 24748645 | |
| Pubmed | Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal. | 7.03e-05 | 6 | 76 | 2 | 29547716 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 12398767 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 27732843 | ||
| Pubmed | Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski. | 7.03e-05 | 6 | 76 | 2 | 14761981 | |
| Pubmed | 8.01e-05 | 38 | 76 | 3 | 28680062 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SETDB1 SETD2 KIAA1217 IQSEC2 DVL2 RPRD2 ATG2A GMIP SYDE1 TNS3 | 8.61e-05 | 1038 | 76 | 10 | 26673895 |
| Pubmed | 9.35e-05 | 40 | 76 | 3 | 28805822 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 9.50e-05 | 108 | 76 | 4 | 19531213 | |
| Pubmed | Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1. | 9.83e-05 | 7 | 76 | 2 | 21149449 | |
| Pubmed | 1.01e-04 | 339 | 76 | 6 | 30415952 | ||
| Pubmed | 1.25e-04 | 44 | 76 | 3 | 27505670 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 17053159 | ||
| Pubmed | A phenotype-based screen for embryonic lethal mutations in the mouse. | 1.31e-04 | 8 | 76 | 2 | 9636176 | |
| Pubmed | 1.31e-04 | 689 | 76 | 8 | 36543142 | ||
| Pubmed | 1.62e-04 | 233 | 76 | 5 | 37704626 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 1.68e-04 | 9 | 76 | 2 | 23144817 | |
| Pubmed | 1.72e-04 | 916 | 76 | 9 | 32203420 | ||
| Pubmed | 2.00e-04 | 733 | 76 | 8 | 34672954 | ||
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 2.10e-04 | 10 | 76 | 2 | 29276034 | |
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 3.07e-04 | 12 | 76 | 2 | 17707229 | |
| Pubmed | 3.07e-04 | 12 | 76 | 2 | 21402781 | ||
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 3.07e-04 | 12 | 76 | 2 | 31911863 | |
| Pubmed | 3.13e-04 | 418 | 76 | 6 | 34709266 | ||
| Pubmed | Hedgehog inhibits β-catenin activity in synovial joint development and osteoarthritis. | 3.62e-04 | 13 | 76 | 2 | 27018594 | |
| Pubmed | 3.62e-04 | 13 | 76 | 2 | 9155018 | ||
| Pubmed | 3.64e-04 | 1014 | 76 | 9 | 32416067 | ||
| Pubmed | 3.97e-04 | 65 | 76 | 3 | 22496869 | ||
| Pubmed | 3.98e-04 | 157 | 76 | 4 | 30186101 | ||
| Pubmed | 4.22e-04 | 14 | 76 | 2 | 36776133 | ||
| Pubmed | 4.22e-04 | 14 | 76 | 2 | 12482968 | ||
| Pubmed | Pellino-2 in nonimmune cells: novel interaction partners and intracellular localization. | 4.22e-04 | 14 | 76 | 2 | 34674267 | |
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 4.34e-04 | 67 | 76 | 3 | 22321011 | |
| Pubmed | 4.74e-04 | 69 | 76 | 3 | 32238831 | ||
| Pubmed | SETDB1 REPS1 IQSEC2 MBD1 YLPM1 CUL9 ROBO1 EIF4G3 CREBBP SOS2 | 4.77e-04 | 1285 | 76 | 10 | 35914814 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 5.15e-04 | 71 | 76 | 3 | 28319113 | |
| Pubmed | Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. | 5.54e-04 | 16 | 76 | 2 | 27721240 | |
| Pubmed | 5.93e-04 | 472 | 76 | 6 | 38943005 | ||
| Pubmed | 6.12e-04 | 1327 | 76 | 10 | 32694731 | ||
| Pubmed | Stage-specific regulation of oligodendrocyte development by Wnt/β-catenin signaling. | 6.27e-04 | 17 | 76 | 2 | 24948802 | |
| Pubmed | 6.27e-04 | 17 | 76 | 2 | 14519686 | ||
| Pubmed | 6.27e-04 | 17 | 76 | 2 | 12464179 | ||
| Pubmed | 6.66e-04 | 1103 | 76 | 9 | 34189442 | ||
| Pubmed | 7.87e-04 | 19 | 76 | 2 | 20219685 | ||
| Interaction | SP7 interactions | 1.18e-06 | 304 | 71 | 9 | int:SP7 | |
| Interaction | CRX interactions | 3.06e-06 | 254 | 71 | 8 | int:CRX | |
| Interaction | HNF4A interactions | 5.49e-06 | 275 | 71 | 8 | int:HNF4A | |
| Interaction | SIN3A interactions | 7.28e-06 | 380 | 71 | 9 | int:SIN3A | |
| Interaction | TIAM1 interactions | 7.80e-06 | 205 | 71 | 7 | int:TIAM1 | |
| Interaction | NFIC interactions | 9.12e-06 | 210 | 71 | 7 | int:NFIC | |
| Interaction | HNF1A interactions | 9.21e-06 | 80 | 71 | 5 | int:HNF1A | |
| Interaction | ERG interactions | 1.35e-05 | 223 | 71 | 7 | int:ERG | |
| Interaction | GSC interactions | 1.39e-05 | 87 | 71 | 5 | int:GSC | |
| Interaction | FOXK2 interactions | 1.43e-05 | 225 | 71 | 7 | int:FOXK2 | |
| Interaction | EPG5 interactions | 1.85e-05 | 15 | 71 | 3 | int:EPG5 | |
| Interaction | GLI3 interactions | 2.48e-05 | 98 | 71 | 5 | int:GLI3 | |
| Interaction | ABL1 interactions | 3.52e-05 | 259 | 71 | 7 | int:ABL1 | |
| Interaction | TEAD1 interactions | 3.65e-05 | 176 | 71 | 6 | int:TEAD1 | |
| Interaction | ATF7IP2 interactions | 3.90e-05 | 19 | 71 | 3 | int:ATF7IP2 | |
| Interaction | TBR1 interactions | 4.92e-05 | 113 | 71 | 5 | int:TBR1 | |
| Interaction | PPP1CC interactions | CBLL1 SRRM1 SIN3B KIAA1217 PHACTR4 YLPM1 PPP1R13B PPP1R3F RPRD2 VIRMA CREBBP | 5.09e-05 | 738 | 71 | 11 | int:PPP1CC |
| Interaction | HNF1B interactions | 5.59e-05 | 190 | 71 | 6 | int:HNF1B | |
| Interaction | PAPPA interactions | 6.15e-05 | 22 | 71 | 3 | int:PAPPA | |
| Interaction | DNAJC6 interactions | 7.66e-05 | 64 | 71 | 4 | int:DNAJC6 | |
| Interaction | VASP interactions | 7.84e-05 | 294 | 71 | 7 | int:VASP | |
| Interaction | CPSF6 interactions | 9.28e-05 | 526 | 71 | 9 | int:CPSF6 | |
| Interaction | SH3BP4 interactions | 9.57e-05 | 130 | 71 | 5 | int:SH3BP4 | |
| Interaction | GCM1 interactions | 9.72e-05 | 68 | 71 | 4 | int:GCM1 | |
| Interaction | MYB interactions | 1.07e-04 | 133 | 71 | 5 | int:MYB | |
| Interaction | POLR2A interactions | 1.07e-04 | 536 | 71 | 9 | int:POLR2A | |
| Interaction | WWTR1 interactions | 1.16e-04 | 422 | 71 | 8 | int:WWTR1 | |
| Interaction | ATF7IP interactions | 1.27e-04 | 138 | 71 | 5 | int:ATF7IP | |
| Interaction | NFIX interactions | 1.49e-04 | 227 | 71 | 6 | int:NFIX | |
| Interaction | ACTC1 interactions | 1.52e-04 | 694 | 71 | 10 | int:ACTC1 | |
| Interaction | AFDN interactions | 1.70e-04 | 333 | 71 | 7 | int:AFDN | |
| Interaction | SOX7 interactions | 2.01e-04 | 82 | 71 | 4 | int:SOX7 | |
| Interaction | CTNNA1 interactions | 2.18e-04 | 347 | 71 | 7 | int:CTNNA1 | |
| Interaction | ANKS1B interactions | 2.32e-04 | 34 | 71 | 3 | int:ANKS1B | |
| Interaction | CREBBP interactions | 2.46e-04 | 599 | 71 | 9 | int:CREBBP | |
| Interaction | CPEB2 interactions | 2.75e-04 | 36 | 71 | 3 | int:CPEB2 | |
| Interaction | FOXI1 interactions | 3.13e-04 | 92 | 71 | 4 | int:FOXI1 | |
| Interaction | CRK interactions | 3.22e-04 | 370 | 71 | 7 | int:CRK | |
| Interaction | EP300 interactions | NUTM1 KMT2D TCF7L2 PHF23 ATXN7 MBD1 YLPM1 DVL2 PPP1R13B ELK1 VIRMA CREBBP GAA SCAF4 | 3.27e-04 | 1401 | 71 | 14 | int:EP300 |
| Interaction | ORAI2 interactions | 3.38e-04 | 8 | 71 | 2 | int:ORAI2 | |
| Interaction | KHDRBS1 interactions | 3.38e-04 | 373 | 71 | 7 | int:KHDRBS1 | |
| Interaction | EGR2 interactions | 3.44e-04 | 171 | 71 | 5 | int:EGR2 | |
| Interaction | TLE3 interactions | 3.55e-04 | 376 | 71 | 7 | int:TLE3 | |
| Interaction | YWHAG interactions | TAOK2 NHSL1 SRRM1 IQSEC2 MBD1 PHACTR4 DVL2 ANKRD34A ARHGAP17 EIF4G3 VIRMA SYDE1 TNS3 | 3.71e-04 | 1248 | 71 | 13 | int:YWHAG |
| Interaction | TLX1 interactions | 3.82e-04 | 175 | 71 | 5 | int:TLX1 | |
| Interaction | SOX9 interactions | 3.83e-04 | 97 | 71 | 4 | int:SOX9 | |
| Interaction | HSPG2 interactions | 3.98e-04 | 98 | 71 | 4 | int:HSPG2 | |
| Interaction | YAP1 interactions | SIN3B SETD2 KMT2D REPS1 ZPR1 YLPM1 KDM2B RPRD2 CREBBP CCNK NSD3 SCAF4 | 4.08e-04 | 1095 | 71 | 12 | int:YAP1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 7.52e-05 | 8 | 76 | 2 | chr9q12 | |
| Cytoband | 9q22 | 4.54e-04 | 19 | 76 | 2 | 9q22 | |
| Cytoband | 9p13.1 | 7.29e-04 | 24 | 76 | 2 | 9p13.1 | |
| Cytoband | 17p13.1 | 1.01e-03 | 118 | 76 | 3 | 17p13.1 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.08e-06 | 34 | 54 | 4 | 487 | |
| GeneFamily | PHD finger proteins | 1.50e-04 | 90 | 54 | 4 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.02e-04 | 181 | 54 | 5 | 694 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.47e-04 | 50 | 54 | 3 | 721 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 4.73e-04 | 11 | 54 | 2 | 1025 | |
| GeneFamily | Zinc fingers CXXC-type | 5.67e-04 | 12 | 54 | 2 | 136 | |
| Coexpression | GSE14308_TH2_VS_INDUCED_TREG_DN | 1.44e-06 | 200 | 73 | 7 | M3367 | |
| Computational | Neighborhood of RPA2 | 4.84e-04 | 193 | 37 | 5 | MORF_RPA2 | |
| Computational | Neighborhood of USP5 | 7.39e-04 | 52 | 37 | 3 | MORF_USP5 | |
| Computational | Neighborhood of PHB | 8.55e-04 | 125 | 37 | 4 | MORF_PHB | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.16e-06 | 176 | 70 | 7 | 4632_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.57e-06 | 184 | 70 | 7 | 1064_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.01e-06 | 191 | 70 | 7 | 4279_DN | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.31e-06 | 195 | 70 | 7 | 7432_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.39e-06 | 196 | 70 | 7 | 3233_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 3338_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 6091_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 7201_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 4448_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.64e-06 | 199 | 70 | 7 | 2402_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.82e-05 | 178 | 70 | 6 | 4184_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.13e-05 | 183 | 70 | 6 | 5613_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.19e-05 | 184 | 70 | 6 | 2321_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.70e-05 | 191 | 70 | 6 | 2627_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.79e-05 | 192 | 70 | 6 | 849_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 3539_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 3285_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 3.04e-05 | 195 | 70 | 6 | 2004_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 4664_DN | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 2382_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 7226_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 1481_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 7317_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A | 3.13e-05 | 196 | 70 | 6 | 2015_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 3327_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 1658_UP | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.13e-05 | 196 | 70 | 6 | 874_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 4761_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 5576_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 4555_UP | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 1671_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 2514_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 5811_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3292_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3180_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.22e-05 | 197 | 70 | 6 | 825_DN | |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 2275_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; HL60; HG-U133A | 3.22e-05 | 197 | 70 | 6 | 1747_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 5431_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 4343_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7500_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6228_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 2303_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; HL60; HG-U133A | 3.31e-05 | 198 | 70 | 6 | 1412_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 7421_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 7126_DN | |
| Drug | benserazide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.40e-05 | 199 | 70 | 6 | 641_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 7471_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.33e-04 | 180 | 70 | 5 | 1793_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.33e-04 | 180 | 70 | 5 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.46e-04 | 182 | 70 | 5 | 1891_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.46e-04 | 182 | 70 | 5 | 1951_DN | |
| Drug | Gh32 | 2.58e-04 | 8 | 70 | 2 | CID000148075 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.58e-04 | 184 | 70 | 5 | 1007_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 2.65e-04 | 185 | 70 | 5 | 5439_DN | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.92e-04 | 189 | 70 | 5 | 4401_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 7070_UP | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 3331_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 7145_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 6024_DN | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 7438_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 6020_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3188_DN | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 7548_UP | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3505_DN | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A | 3.14e-04 | 192 | 70 | 5 | 1623_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.22e-04 | 193 | 70 | 5 | 1048_DN | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; PC3; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 6677_DN | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 3.22e-04 | 193 | 70 | 5 | 948_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 1155_DN | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 3213_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7481_DN | |
| Drug | Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 6774_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5544_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5696_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7036_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 3674_DN | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2397_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 1185_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4721_DN | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2515_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 1179_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4320_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5047_DN | |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4251_DN | |
| Drug | 5194442; Up 200; 20uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 6558_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5318_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3714_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3237_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3300_UP | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 6082_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 3358_DN | |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 7460_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3217_DN | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 6653_DN | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 5015_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 5411_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2856_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 7470_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 5261_DN | |
| Disease | Cleft palate, cleft lip | 5.46e-06 | 279 | 72 | 7 | EFO_0003959, HP_0000175 | |
| Disease | malignant pleural mesothelioma (is_implicated_in) | 3.51e-05 | 4 | 72 | 2 | DOID:7474 (is_implicated_in) | |
| Disease | Phyllodes Tumor | 5.84e-05 | 5 | 72 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 5.84e-05 | 5 | 72 | 2 | C0600066 | |
| Disease | renal overload-type gout | 8.75e-05 | 6 | 72 | 2 | EFO_0021525 | |
| Disease | panhypopituitarism (is_implicated_in) | 1.22e-04 | 7 | 72 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | eosinophil cationic protein measurement | 1.63e-04 | 8 | 72 | 2 | EFO_0010913 | |
| Disease | longitudinal alcohol consumption measurement | 2.09e-04 | 9 | 72 | 2 | EFO_0007645 | |
| Disease | schizophrenia, anorexia nervosa | 2.23e-04 | 48 | 72 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Huntington's disease (is_marker_for) | 2.99e-04 | 53 | 72 | 3 | DOID:12858 (is_marker_for) | |
| Disease | egg allergy measurement, parental genotype effect measurement | 4.50e-04 | 13 | 72 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | platelet component distribution width | 5.00e-04 | 755 | 72 | 8 | EFO_0007984 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 5.24e-04 | 14 | 72 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Lymphoma, Large-Cell, Follicular | 6.04e-04 | 15 | 72 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 6.04e-04 | 15 | 72 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 6.04e-04 | 15 | 72 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 6.04e-04 | 15 | 72 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 6.04e-04 | 15 | 72 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 6.04e-04 | 15 | 72 | 2 | C1956130 | |
| Disease | amygdala volume change measurement | 6.89e-04 | 16 | 72 | 2 | EFO_0021490 | |
| Disease | Prostatic Neoplasms | 7.61e-04 | 616 | 72 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.61e-04 | 616 | 72 | 7 | C0376358 | |
| Disease | syndrome (implicated_via_orthology) | 8.76e-04 | 18 | 72 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | body weight | SETD2 TCF7L2 MICALL2 KIAA1217 RIN2 MBD1 SPATA31C2 ARHGAP8 SPATA31C1 VIRMA | 9.44e-04 | 1261 | 72 | 10 | EFO_0004338 |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 9.77e-04 | 19 | 72 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Lymphoma, Follicular | 1.08e-03 | 20 | 72 | 2 | C0024301 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.19e-03 | 189 | 72 | 4 | EFO_0009932 | |
| Disease | mean corpuscular hemoglobin concentration | 1.44e-03 | 1105 | 72 | 9 | EFO_0004528 | |
| Disease | Neurodevelopmental Disorders | 1.54e-03 | 93 | 72 | 3 | C1535926 | |
| Disease | colorectal cancer, breast carcinoma | 1.84e-03 | 26 | 72 | 2 | EFO_0000305, MONDO_0005575 | |
| Disease | Sezary Syndrome | 1.98e-03 | 27 | 72 | 2 | C0036920 | |
| Disease | treatment-resistant hypertension | 2.43e-03 | 109 | 72 | 3 | EFO_1002006 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPHPRPAVVLPSAA | 171 | P19419 | |
| LVELPHVRAPPPPPP | 46 | Q6ZU67 | |
| PPPPPPFAPHAAVSI | 56 | Q6ZU67 | |
| NFPPPPPRLPPTHAV | 516 | O75909 | |
| PPVTQSPLHPTPPPA | 846 | Q92793 | |
| PRPPQPSKTVPPHYP | 136 | O75618 | |
| PPVHEPRAELAPPAP | 101 | O14641 | |
| EQVPPAPLPPASHPP | 846 | Q96KQ4 | |
| GDLHPPPRPPSPTEI | 1241 | Q2TAZ0 | |
| PPLNVSPHPPIPDIR | 426 | Q69YU3 | |
| VIHSPPPPPPPAVLA | 316 | P78411 | |
| PHEPPPPRPHDVTLV | 421 | Q8N3Y3 | |
| PPPPHLDPDSQPPVL | 786 | Q9P107 | |
| ISSPRPHQRMPPPPP | 1171 | Q5JU85 | |
| PPPPSQSPEPTEPHP | 291 | Q9UIS9 | |
| HSPVFPPPPPEALIP | 971 | Q5SYE7 | |
| HPAVPPSAPDPRPAT | 361 | Q8IY33 | |
| PPPHRTYLTVPPAPP | 56 | A0A1B0GUC4 | |
| VPSPRPPVPHESPEP | 81 | Q8N159 | |
| PPVPHESPEPPSGRS | 86 | Q8N159 | |
| RSPSPPLPTHIPPEP | 341 | Q8IZ21 | |
| APIDPPPVHESPHPP | 466 | O15265 | |
| LPPTSDPPDHPPREP | 31 | Q86Y26 | |
| HPPIAPPPTEIPERF | 206 | Q75N03 | |
| AREKVAEPPPPPPPH | 156 | Q14549 | |
| AEPPPPPPPHFSETF | 161 | Q14549 | |
| HVIRPPPISPPPDSL | 1041 | Q8NHM5 | |
| RPPASSPEDPPLPHP | 81 | Q8N9R0 | |
| TEPPRPVHPAPLPEA | 1131 | Q6VMQ6 | |
| LPPPPAAPREPAIHS | 786 | P10253 | |
| RAPSPVPAPAPEPEP | 281 | Q12967 | |
| HVEPPPGPSPEPSTR | 1431 | Q8IWT3 | |
| LPSPHPTRPPSRPPS | 791 | Q9NZM4 | |
| TPPPPPPPVDHSGVV | 1291 | Q5VT52 | |
| VPAPITVPPPQVPPH | 671 | O95104 | |
| PPASPPHTPVIVPAA | 421 | O43432 | |
| PPPPPEPPKTAVAHA | 176 | Q9NWU5 | |
| HPAQRPEPSPPEPEP | 31 | Q6ZW31 | |
| VPPELLVPPTPHPRP | 581 | O15034 | |
| LVPPTPHPRPAPQSK | 586 | O15034 | |
| PPPPPPRPQPSHSRS | 546 | Q96D71 | |
| HSPPPPPPRDPLPDT | 1201 | Q07890 | |
| THVRSPQPPPPAPAP | 501 | O15240 | |
| PPALFPHPPRTPDPL | 206 | B4DYI2 | |
| PHPPRTPDPLACSPP | 211 | B4DYI2 | |
| RPSVPPPPQPPGVHS | 806 | Q68EM7 | |
| PPEPSLPLEHPSPEP | 186 | Q5VVP1 | |
| PPEPSLPLEHPSPEP | 186 | Q8IWB4 | |
| PPHAIPNSPPSTPVP | 306 | Q5T5P2 | |
| APATEQPPLPPPAPH | 751 | O75182 | |
| CPSPDIPPEPPPTHL | 921 | Q9UL54 | |
| IPPEPPPTHLRPCPA | 926 | Q9UL54 | |
| ERPSPEPPALFPHPP | 206 | P0DKV0 | |
| RHPPFSPPEPPLSSP | 861 | Q68CZ2 | |
| PPPPTQPPSRHVPHE | 336 | Q8NA69 | |
| PAPVPAATEPPPVLH | 61 | P12755 | |
| PVNPPPPSPEAPSHK | 206 | Q8N4L4 | |
| DLGPPHIPVPPSIPV | 951 | Q15047 | |
| PPEPSLPLEHPSPEP | 186 | Q5VYP0 | |
| SPPPRPPPPAINSLH | 306 | Q8WYP3 | |
| VAPSPAPAPPPAPDH | 16 | O75312 | |
| HAPLPPTSPQPPEEP | 216 | Q96LT9 | |
| IPPPTRPLPTVPPHR | 296 | P51512 | |
| PPEPSLPLEHPSPEP | 186 | Q5TZJ5 | |
| PPEPSLPLEHPSPEP | 186 | Q5VU36 | |
| PAPEAPHPPQLAPPE | 11 | Q8WVT3 | |
| PSPPATPPPKTRHSP | 401 | Q8IYB3 | |
| PKTGIPRPPHPPDIS | 226 | Q9NQB0 | |
| PVEPPLRHSAPPSPA | 6 | Q6ZSY5 | |
| VSPPPPPRPISPPHT | 1296 | Q9Y6N7 | |
| PTPPEAPRPPATVHP | 276 | Q9BUL5 | |
| APRPPATVHPEGVPP | 281 | Q9BUL5 | |
| APPPELHPPAPAPST | 686 | Q99835 | |
| PHEILEKPSPPQPPP | 121 | Q9BZ95 | |
| PLSAPPPVPVVPHVA | 2216 | Q9BYW2 | |
| PPPPPHAPDAFPRIA | 346 | O14512 | |
| PPVHSSIPPPGPVPM | 1611 | P49750 | |
| LHEGRTPPPTKTPPP | 201 | P85298 | |
| QPPPPPPKTEDHDTP | 201 | O15060 | |
| HAVLPPPKQPSPSPP | 6 | Q9HA38 | |
| ENPPPPPPPVIFCHD | 11 | Q7RTV3 | |
| VISHDRDSPPPPPPP | 131 | Q69YN4 | |
| HHPTVIVPAPPPPPS | 231 | Q01664 | |
| HPTPPPSSPQEPKRP | 4306 | O14686 |